Therapeutic Potential of Mesenchymal Stem Cells in Psoriasis
Open Access
- 1 August 2025
- journal article
- review article
- Published by Springer Nature in Cell Biochemistry and Biophysics
- Vol. 83 (4) , 4217-4231
Abstract
Psoriasis is a chronic immune-mediated disease mainly affecting the skin with different clinical manifestations. As patients with psoriasis may also suffer from psoriatic arthritis and the skin lesions of psoriasis are disfiguring, their quality of life is often impaired. Many environmental and genetic factors have been implicated in psoriasis development. Currently, there is no cure for the disease and long-term drug treatment is usually necessary, especially in moderate to severe cases. Mesenchymal stem cells (MSCs) are popular candidates for cell-based treatment in many immune-mediated diseases due to their ability to secrete a wide array of cytokines and growth factors and their immunomodulatory properties. MSCs from various sources administered via different routes have been shown to ameliorate psoriasis. This review gives an overview of psoriasis and MSCs and examine preclinical and clinical studies concerning the application of MSCs in the treatment of psoriasis, as well as consolidate major findings in this area of research.Keywords
Funding Information
- Sunway University (GRTIN-ECR-SBMDC-05-2024, GRTIN-RAG-SBMDC-10-2024)
This publication has 78 references indexed in Scilit:
- Analysis of PEST Questionnaire Responses in Patients with Psoriasis in Daily Practice: Results from a Single-Center of Psoriasis in the Czech RepublicDermatology and Therapy, 2025
- Differential effects of TLR3 and TLR4 activation on MSC-mediated immune regulationBiochemistry and Biophysics Reports, 2024
- Extracellular vesicles arising from apoptosis: forms, functions, and applicationsThe Journal of Pathology, 2023
- Human Umbilical Cord-Derived Mesenchymal Stem Cells Alleviate Psoriasis Through TNF-α/NF-κB/MMP13 PathwayInflammation, 2023
- Pain Medication and Corticosteroid Use in Ankylosing Spondylitis, Psoriatic Arthritis, and Rheumatoid Arthritis in the United States: A Retrospective Observational StudyRheumatology and Therapy, 2021
- The mechanisms of cellular crosstalk between mesenchymal stem cells and natural killer cells: Therapeutic implicationsJournal of Cellular Physiology, 2020
- RETRACTED: Bone marrow-derived mesenchymal stem cells-secreted exosomal microRNA-192-5p delays inflammatory response in rheumatoid arthritisInternational Immunopharmacology, 2020
- Human Embryonic Stem Cells-Derived Mesenchymal Stem Cells Reduce the Symptom of Psoriasis in Imiquimod-Induced Skin ModelTissue Engineering and Regenerative Medicine, 2018
- Metabolic comorbidities and hypertension in psoriasis patients in France. Comparisons with French national databasesAnnales de Dermatologie et de Vénéréologie, 2016
- Treatment of Psoriasis with Mesenchymal Stem CellsThe American Journal of Medicine, 2016